Indivior Pharmaceuticals, Inc. Liquidation Value
INDV
Other
Cash & Equivalents
$195.00M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $195.00M
Total Obligations: -$1.24B
$-1.04B
Per share: $-8.33
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $195.00M
AR: $253.00M
Total Obligations: -$1.24B
$-788.00M
Per share: $-6.30
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $195.00M
AR: $253.00M
Inventory: $153.00M
Total Obligations: -$1.24B
$-635.00M
Per share: $-5.08
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-1.04B | $-8.33 |
| Liquid Liquidation Value | $-788.00M | $-6.30 |
| Operating Liquidation Value | $-635.00M | $-5.08 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $195.00M |
| Accounts Receivable | $253.00M |
| Inventory | $153.00M |
| Current Liabilities | $914.00M |
| Long-term Debt | $290.00M |
| Op. Lease Liability | $32.00M |
| Finance Lease | N/A |
| Shares Outstanding | 125.0M |
Explore all 203 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $195.00M | $253.00M | $153.00M | $48.00M | $914.00M | $290.00M | $32.00M | N/A |
| 2025-09-30 | $445.00M | $259.00M | $155.00M | $41.00M | $965.00M | $304.00M | $34.00M | N/A |
| 2025-06-30 | $510.00M | $240.00M | $149.00M | $50.00M | $1.06B | $308.00M | $40.00M | N/A |
| 2025-03-31 | $372.00M | $243.00M | $163.00M | $46.00M | $1.00B | $311.00M | $41.00M | N/A |
| 2024-12-31 | $319.00M | $254.00M | $167.00M | $63.00M | $924.00M | $315.00M | $42.00M | N/A |
| 2024-09-30 | $288.00M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024-06-30 | $302.00M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024-03-31 | $248.00M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
▼ Community Notes